Who Owns Takeda Pharmaceutical Stock?
NYSE: TAKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 18.60 +0.43%
Ownership breakdown
- Held by institutions
- 3.31%
- Held by insiders
- 0.07%
- Institutional holders
- 449
- Institutions 3.3%
- Insiders 0.1%
- Public and other 96.6%
Who owns Takeda Pharmaceutical stock?
Institutional investors own about 3.3% of Takeda Pharmaceutical's shares, spread across 449 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.07% of TAK.
The largest institutional holders are Capital Research Global Investors (0.60%), FMR, LLC (0.30%) and Morgan Stanley (0.22%). Together, the top 10 institutions control 2.0% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TAK positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TAK
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Capital Research Global Investors | 19.30M | 0.60% | +1.0% |
| FMR, LLC | 9.60M | 0.30% | +34.9% |
| Morgan Stanley | 6.99M | 0.22% | +8.1% |
| Adage Capital Partners GP L.L.C. | 6.05M | 0.19% | -5.8% |
| Goldman Sachs Group Inc | 5.13M | 0.16% | -8.8% |
| Brandes Investment Partners L.P. | 4.54M | 0.14% | +2.5% |
| Arrowstreet Capital, Limited Partnership | 3.73M | 0.12% | +19.8% |
| Blackrock Inc. | 3.69M | 0.12% | +16.1% |
| Renaissance Technologies, LLC | 2.57M | 0.08% | -14.1% |
| Qube Research & Technologies Ltd | 2.21M | 0.07% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TAK
| Fund | Shares | % Held |
|---|---|---|
| AMERICAN MUTUAL FUND | 18.16M | 0.57% |
| Capital Income Builder | 7.34M | 0.23% |
| First TRT Exch-Trd Fd.-First TRT Value Line Dividend Index Fd. | 1.88M | 0.06% |
| VanEck ETF Trust-VanEck Pharmaceutical ETF | 1.79M | 0.06% |
| Steward Funds Inc-Steward Values Enhanced International Fund | 711.87K | 0.02% |
| Mercer Funds-Mercer Non-US Core Equity Fund | 586.10K | 0.02% |
| American Century ETF Trust-Avantis International Equity ETF | 553.01K | 0.02% |
| GOLDMAN SACHS TRUST-Goldman Sachs Income Builder Fund | 494.44K | 0.02% |
| Trust for Professional Managers-ActivePassive International Equity ETF | 170.11K | 0.01% |
| MUTUAL FUND SERIES TRUST-Catalyst/MAP Global Equity Fund | 169.00K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Takeda Pharmaceutical?
Capital Research Global Investors is the largest institutional shareholder of TAK, owning 0.60% of shares outstanding (19.30M shares) as of its latest 13F filing.
What percentage of Takeda Pharmaceutical is owned by institutions?
Institutions own about 3.3% of TAK shares and 3.3% of the public float.
How much of Takeda Pharmaceutical do insiders own?
Insiders, such as officers and directors, own about 0.07% of TAK shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.